trader06510

trader06510

Novavax, NASDAQ:NVAX phase 3 trial begins on 12/9/2024. ctv.veeva.com A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

trader06510

NASDAQ:NVAX Novavax stock, $24 on 12/9/24. ctv.veeva.com Phase 3 trial begins on Monday, Dec. 9, 2024. Squeezing.

trader06510

Micron squeeze. 1.4 days to cover. Micron Technology Inc $ 108.08 MU -3.82 Short Interest Ratio (Days To Cover) 1.4 Short Interest (Shares Short) 35,200,000

trader06510

Is NASDAQ:MU Micron is getting ready for a huge move? Double bottom price target $137. Falling wedge price target $170.

trader06510

Is Micron is getting ready for a big move? Double bottom price target $137. Falling wedge price target $170

trader06510

Enviox targets: $42.10 double bottom, $46.90 triple bottom, $47.60 falling wedge targets all possible.

trader06510

Novavax, incoming possible $44.32 target due to head and shoulders pattern and falling wedge.

trader06510

NVAX inverse head and shoulders target of $44.32 by September 2024? Weekly projected chart coming off right shoulder with targets.

trader06510

Novovax falling wedge target projection of $25.59 based on projections using $3.81 in April 2024 and $23.86 from June 2024

trader06510

NASDAQ:NVAX incoming long projected falling wedge. Based on projected script